• 1. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 2. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 3. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 4. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548
• 5. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527

Introduction to 3-(difluoromethoxy)-5-fluorophenol (CAS No. 1261441-59-1)

3-(difluoromethoxy)-5-fluorophenol, identified by the chemical abstracts service number CAS No. 1261441-59-1, is a fluorinated aromatic compound that has garnered significant attention in the field of pharmaceutical chemistry and materials science. This compound, featuring a difluoromethoxy substituent at the 3-position and a fluorine atom at the 5-position of the phenol ring, exhibits unique structural and electronic properties that make it a valuable intermediate in the synthesis of various bioactive molecules.

The difluoromethoxy group introduces electron-withdrawing effects through the fluorine atoms, which can influence the reactivity and binding affinity of the molecule. This feature is particularly relevant in drug design, where modulating electronic properties can enhance interactions with biological targets. The presence of two fluorine atoms in close proximity also suggests potential for strong dipole moments, which may contribute to improved solubility and bioavailability in certain applications.

Recent research has highlighted the utility of 3-(difluoromethoxy)-5-fluorophenol as a building block in the development of novel therapeutic agents. For instance, studies have demonstrated its role in synthesizing fluorinated phenols, which are known for their antimicrobial and anti-inflammatory properties. The fluorine atoms at the 5-position can enhance metabolic stability by preventing rapid degradation, a critical factor in drug formulation. Additionally, the difluoromethoxy group can serve as a handle for further functionalization, allowing chemists to tailor the molecule for specific biological activities.

In materials science, 3-(difluoromethoxy)-5-fluorophenol has been explored for its potential applications in organic electronics and liquid crystal displays (LCDs). The electron-withdrawing nature of the fluorinated groups can influence charge transport properties, making it a candidate for use in semiconducting materials. Furthermore, its ability to form hydrogen bonds due to the hydroxyl group opens up possibilities for designing high-performance polymers with enhanced thermal and mechanical stability.

The synthesis of 3-(difluoromethoxy)-5-fluorophenol typically involves multi-step organic transformations, including halogenation, methylation, and selective functionalization of the aromatic ring. Advanced synthetic methodologies such as cross-coupling reactions and palladium-catalyzed transformations have been employed to achieve high yields and purity. These synthetic strategies are crucial for producing pharmaceutical intermediates that meet stringent regulatory requirements.

From a pharmacological perspective, derivatives of 3-(difluoromethoxy)-5-fluorophenol have shown promise in preclinical studies as potential treatments for various diseases. The combination of electronic and steric effects introduced by fluorine atoms can optimize binding interactions with enzymes and receptors. For example, modifications at the 3- and 5-positions have been investigated for their impact on receptor selectivity, which is essential for minimizing side effects in drug development.

The environmental impact of using fluorinated compounds like 3-(difluoromethoxy)-5-fluorophenol is also a topic of interest. While fluorine-based compounds offer numerous advantages in terms of chemical stability and bioactivity, their persistence in the environment raises concerns about long-term ecological effects. Researchers are actively exploring greener synthetic routes and biodegradable alternatives to mitigate these issues while maintaining the desired pharmacological properties.

In conclusion, 3-(difluoromethoxy)-5-fluorophenol (CAS No. 1261441-59-1) is a versatile compound with significant applications in pharmaceuticals and materials science. Its unique structural features enable diverse functionalization strategies, making it a valuable asset in drug discovery and advanced material design. As research continues to uncover new applications for this compound, it will remain a key player in innovation across multiple scientific disciplines.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)